Abstract
Although the monomeric GTPases RalA and RalB have been shown to regulate a variety of transcription factors, little is known regarding the differences or similarities in transcriptional programs regulated by RalA compared to RalB. Further, the association of these transcriptional pathways to human carcinogenesis and progression remains unclear. Here, we studied the role of RalA and/or RalB in transcriptional regulation by combining short interfering RNA depletion of Ral with gene expression profiling via microarray in the human bladder cancer cell line, UMUC-3. A large number of genes were found to be similarly modulated in cells with RalA and RalB depletion, suggesting that RalA and RalB impinge on overlapping transcriptional signaling pathways. However, smaller sets of genes were modulated by depletion of RalA or RalB, indicating that these closely related proteins also regulate nonoverlapping transcriptional pathways. Computational analysis of upstream sequences of genes modulated by Ral depletion identified Ras-responsive element-binding protein (RREB)-1, as a putative Ral transcriptional target, which we verified experimentally. Importantly, as a group, Ral-regulated probe sets identified here were disproportionally represented among those differentially expressed as a function of human bladder transformation. Taken together, these data strongly suggest that Ral family members mediate both common and specific transcriptional programs that are associated with human cancer and identify RREB-1 as a novel transcriptional effector of Ral.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Awasthi S, Cheng J, Singhal SS, Saini MK, Pandya U, Pikula S et al. (2000). Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin. Biochemistry 39: 9327–9334.
Awasthi S, Singhal SS, Sharma R, Zimniak P, Awasthi YC . (2003). Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance. Int J Cancer 106: 635–646.
Bigler D, Gulding KM, Dann R, Sheabar FZ, Conaway MR, Theodorescu D . (2003). Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action. Oncogene 22: 1261–1272.
Camonis JH, White MA . (2005). Ral GTPases: corrupting the exocyst in cancer cells. Trends Cell Biol 15: 327–332.
Carmeliet P . (2005). VEGF as a key mediator of angiogenesis in cancer. Oncology 69 (Suppl 3): 4–10.
Chien Y, White MA . (2003). RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep 4: 800–806.
Dyrskjot L, Kruhoffer M, Thykjaer T, Marcussen N, Jensen JL, Moller K et al. (2004). Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 64: 4040–4048.
Feig LA . (2003). Ral-GTPases: approaching their 15 min of fame. Trends Cell Biol 13: 419–425.
Gildea JJ, Harding MA, Seraj MJ, Gulding KM, Theodorescu D . (2002). The role of Ral A in epidermal growth factor receptor-regulated cell motility. Cancer Res 62: 982–985.
Grossman HB, Wedemeyer G, Ren L, Wilson GN, Cox B . (1986). Improved growth of human urothelial carcinoma cell cultures. J Urol 136: 953–959.
Hamad NM, Elconin JH, Karnoub AE, Bai W, Rich JN, Abraham RT et al. (2002). Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev 16: 2045–2057.
Haverty PM, Frith MC, Weng Z . (2004). CARRIE web service: automated transcriptional regulatory network inference and interactive analysis. Nucleic Acids Res 32: W213–W216.
Henry DO, Moskalenko SA, Kaur KJ, Fu M, Pestell RG, Camonis JH et al. (2000). Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB. Mol Cell Biol 20: 8084–8092.
Jebar AH, Hurst CD, Tomlinson DC, Johnston C, Taylor CF, Knowles MA . (2005). FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma. Oncogene 24: 5218–5225.
Jullien-Flores V, Dorseuil O, Romero F, Letourneur F, Saragosti S, Berger R et al. (1995). Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J Biol Chem 270: 22473–22477.
Lebreton S, Boissel L, Iouzalen N, Moreau J . (2004). RLIP mediates downstream signalling from RalB to the actin cytoskeleton during Xenopus early development. Mech Dev 121: 1481–1494.
Lim KH, Baines AT, Fiordalisi JJ, Shipitsin M, Feig LA, Cox AD et al. (2005). Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 7: 533–545.
Lim KH, O'Hayer K, Adam SJ, Kendall SD, Campbell PM, Der CJ et al. (2006). Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr Biol 16: 2385–2394.
Moskalenko S, Tong C, Rosse C, Mirey G, Formstecher E, Daviet L et al. (2003). Ral GTPases regulate exocyst assembly through dual subunit interactions. J Biol Chem 278: 51743–51748.
Nicholson BE, Frierson HF, Conaway MR, Seraj JM, Harding MA, Hampton GM et al. (2004). Profiling the evolution of human metastatic bladder cancer. Cancer Res 64: 7813–7821.
Ohta Y, Suzuki N, Nakamura S, Hartwig JH, Stossel TP . (1999). The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci USA 96: 2122–2128.
Oxford G, Owens CR, Titus BJ, Foreman TL, Herlevsen MC, Smith SC et al. (2005). RalA and RalB: antagonistic relatives in cancer cell migration. Cancer Res 65: 7111–7120.
Shi Y, Sawada J, Sui G, Affar el B, Whetstine JR, Lan F et al. (2003). Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422: 735–738.
Shipitsin M, Feig LA . (2004). RalA but not RalB enhances polarized delivery of membrane proteins to the basolateral surface of epithelial cells. Mol Cell Biol 24: 5746–5756.
Smith SC, Oxford G, Wu Z, Nitz MD, Conaway M, Frierson HF et al. (2006). The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Res 66: 1917–1922.
Thiagalingam A, De Bustros A, Borges M, Jasti R, Compton D, Diamond L et al. (1996). RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol 16: 5335–5345.
Ward Y, Wang W, Woodhouse E, Linnoila I, Liotta L, Kelly K . (2001). Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways. Mol Cell Biol 21: 5958–5969.
White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M et al. (1995). Multiple Ras functions can contribute to mammalian cell transformation. Cell 80: 533–541.
Wolthuis RM, Zwartkruis F, Moen TC, Bos JL . (1998). Ras-dependent activation of the small GTPase Ral. Curr Biol 8: 471–474.
Wu X, Obata T, Khan Q, Highshaw RA, De Vere White R, Sweeney C . (2004). The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion. BJU Int 93: 143–150.
Zhang S, Qian X, Redman C, Bliskovski V, Ramsay ES, Lowy DR et al. (2003). p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB. Oncogene 22: 2285–2295.
Acknowledgements
This work was supported by Medical Scientist Training Program training grant T32GM007267 to SCS, Cancer Training Grant CA009109-29 to SCS, and CA075115 and PO1CA104106 to DT.
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflict of interest
These authors state no conflict of interest.
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Supplementary information
Rights and permissions
About this article
Cite this article
Oxford, G., Smith, S., Hampton, G. et al. Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector. Oncogene 26, 7143–7152 (2007). https://doi.org/10.1038/sj.onc.1210521
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210521
Keywords
This article is cited by
-
The U2AF65/circNCAPG/RREB1 feedback loop promotes malignant phenotypes of glioma stem cells through activating the TGF-β pathway
Cell Death & Disease (2023)
-
DNA methylation-based classification and identification of renal cell carcinoma prognosis-subgroups
Cancer Cell International (2019)
-
Whole exome sequencing in three families segregating a pediatric case of sarcoidosis
BMC Medical Genomics (2018)
-
Evidence for Changes in RREB-1, ZIP3, and Zinc in the Early Development of Pancreatic Adenocarcinoma
Journal of Gastrointestinal Cancer (2012)
-
Ral GTPases and cancer: linchpin support of the tumorigenic platform
Nature Reviews Cancer (2008)